PAX-8 Expression in Salivary Duct Carcinoma

Appl Immunohistochem Mol Morphol. 2021 Oct 1;29(9):680-684. doi: 10.1097/PAI.0000000000000951.

Abstract

Salivary duct carcinoma (SDC) is a high-grade adenocarcinoma resembling breast ductal carcinoma. It accounts for ~10% of malignant tumors of the salivary glands. Most cases show expression of CK7 and androgen receptor. PAX-8 is a transcription factor, with expression reported in renal, Müllerian, and thyroid carcinomas. Previous studies have described an absence of PAX-8 immunostaining in most primary salivary gland neoplasms, including SDCs. However, PAX-8 expression is frequently found in neoplasms that can metastasize to salivary glands, suggesting the possibility that this protein can be used to differentiate SDC from secondary neoplastic involvement of the salivary gland. We evaluated the expression of PAX-8 in 14 cases of SDC from our institution. One case showed diffuse moderate to strong PAX-8 positivity, while 2 tumors showed focal weak staining. Therefore, we conclude that although the majority of SDC are negative for PAX-8, rare diffuse positivity can be seen in these primary salivary gland tumors. This could potentially pose difficulty in ruling out metastatic disease from another PAX-8-positive primary neoplasm.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Ductal* / metabolism
  • Carcinoma, Ductal* / pathology
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins / biosynthesis*
  • PAX8 Transcription Factor / biosynthesis*
  • Salivary Gland Neoplasms* / metabolism
  • Salivary Gland Neoplasms* / pathology

Substances

  • Neoplasm Proteins
  • PAX8 Transcription Factor
  • PAX8 protein, human